TLR3 Can Directly Trigger Apoptosis in Human Cancer Cells

TLRs function as molecular sensors to detect pathogen-derived products and trigger protective responses ranging from secretion of cytokines that increase the resistance of infected cells and chemokines that recruit immune cells to cell death that limits microbe spreading. Viral dsRNA participate in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Immunology 2006-04, Vol.176 (8), p.4894-4901
Hauptverfasser: Salaun, Bruno, Coste, Isabelle, Rissoan, Marie-Clotilde, Lebecque, Serge J, Renno, Toufic
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4901
container_issue 8
container_start_page 4894
container_title Journal of Immunology
container_volume 176
creator Salaun, Bruno
Coste, Isabelle
Rissoan, Marie-Clotilde
Lebecque, Serge J
Renno, Toufic
description TLRs function as molecular sensors to detect pathogen-derived products and trigger protective responses ranging from secretion of cytokines that increase the resistance of infected cells and chemokines that recruit immune cells to cell death that limits microbe spreading. Viral dsRNA participate in virus-infected cell apoptosis, but the signaling pathway involved remains unclear. In this study we show that synthetic dsRNA induces apoptosis of human breast cancer cells in a TLR3-dependent manner, which involves the molecular adaptor Toll/IL-1R domain-containing adapter inducing IFN-beta and type I IFN autocrine signaling, but occurs independently of the dsRNA-activated kinase. Moreover, detailed molecular analysis of dsRNA-induced cell death established the proapoptotic role of IL-1R-associated kinase-4 and NF-kappaB downstream of TLR3 as well as the activation of the extrinsic caspases. The direct proapoptotic activity of endogenous human TLR3 expressed by cancerous cells reveals a novel aspect of the multiple-faced TLR biology, which may open new clinical prospects for using TLR3 agonists as cytotoxic agents in selected cancers.
doi_str_mv 10.4049/jimmunol.176.8.4894
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67833014</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19837191</sourcerecordid><originalsourceid>FETCH-LOGICAL-c477t-fcf1b95fb832de279b465a35746ebe9492866aabd09e85f756099e07220f9c5f3</originalsourceid><addsrcrecordid>eNqFkMtKw0AUhgdRbK0-gSBZ6SpxJnNflnipUBCkrodJOtNOyc1MQujbO6UV3QkHzuJ8_8_hA-AWwYRAIh93rqqGuikTxFkiEiIkOQNTRCmMGYPsHEwhTNM4XPkEXHm_gxAymJJLMEGMChpmCuRq-YGjTNfRk-tM0Zf7aNW5zcZ00bxt2r7xzkeujhZDFZjAFeGSmbL01-DC6tKbm9Oegc-X51W2iJfvr2_ZfBkXhPM-toVFuaQ2Fzhdm5TLnDCqMeWEmdxIIlPBmNb5GkojqOWUQSkN5GkKrSyoxTNwf-xtu-ZrML5XlfNF-EDXphm8YlxgDBH5F0RSYI4kCiA-gkXXeN8Zq9rOVbrbKwTVQa36UauCPCXUQW1I3Z3qh7wy69_MyWUAHo7A1m22Y7CpfKXLMuBIjeP4p-ob_j6Cyw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19837191</pqid></control><display><type>article</type><title>TLR3 Can Directly Trigger Apoptosis in Human Cancer Cells</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>IngentaConnect Free/Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Salaun, Bruno ; Coste, Isabelle ; Rissoan, Marie-Clotilde ; Lebecque, Serge J ; Renno, Toufic</creator><creatorcontrib>Salaun, Bruno ; Coste, Isabelle ; Rissoan, Marie-Clotilde ; Lebecque, Serge J ; Renno, Toufic</creatorcontrib><description>TLRs function as molecular sensors to detect pathogen-derived products and trigger protective responses ranging from secretion of cytokines that increase the resistance of infected cells and chemokines that recruit immune cells to cell death that limits microbe spreading. Viral dsRNA participate in virus-infected cell apoptosis, but the signaling pathway involved remains unclear. In this study we show that synthetic dsRNA induces apoptosis of human breast cancer cells in a TLR3-dependent manner, which involves the molecular adaptor Toll/IL-1R domain-containing adapter inducing IFN-beta and type I IFN autocrine signaling, but occurs independently of the dsRNA-activated kinase. Moreover, detailed molecular analysis of dsRNA-induced cell death established the proapoptotic role of IL-1R-associated kinase-4 and NF-kappaB downstream of TLR3 as well as the activation of the extrinsic caspases. The direct proapoptotic activity of endogenous human TLR3 expressed by cancerous cells reveals a novel aspect of the multiple-faced TLR biology, which may open new clinical prospects for using TLR3 agonists as cytotoxic agents in selected cancers.</description><identifier>ISSN: 0022-1767</identifier><identifier>EISSN: 1550-6606</identifier><identifier>EISSN: 1365-2567</identifier><identifier>DOI: 10.4049/jimmunol.176.8.4894</identifier><identifier>PMID: 16585585</identifier><language>eng</language><publisher>United States: Am Assoc Immnol</publisher><subject>Apoptosis - immunology ; Base Sequence ; Breast Neoplasms - genetics ; Breast Neoplasms - immunology ; Breast Neoplasms - pathology ; Caspases - metabolism ; Cell Line, Tumor ; DNA, Neoplasm - genetics ; eIF-2 Kinase - metabolism ; Female ; Humans ; Interferon Type I - metabolism ; Interleukin-1 Receptor-Associated Kinases ; Intracellular Signaling Peptides and Proteins - metabolism ; NF-kappa B - metabolism ; Protein-Serine-Threonine Kinases - metabolism ; RNA, Small Interfering - genetics ; Signal Transduction ; TNF Receptor-Associated Factor 6 - metabolism ; Toll-Like Receptor 3 - agonists ; Toll-Like Receptor 3 - genetics ; Toll-Like Receptor 3 - metabolism</subject><ispartof>Journal of Immunology, 2006-04, Vol.176 (8), p.4894-4901</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c477t-fcf1b95fb832de279b465a35746ebe9492866aabd09e85f756099e07220f9c5f3</citedby><cites>FETCH-LOGICAL-c477t-fcf1b95fb832de279b465a35746ebe9492866aabd09e85f756099e07220f9c5f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16585585$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Salaun, Bruno</creatorcontrib><creatorcontrib>Coste, Isabelle</creatorcontrib><creatorcontrib>Rissoan, Marie-Clotilde</creatorcontrib><creatorcontrib>Lebecque, Serge J</creatorcontrib><creatorcontrib>Renno, Toufic</creatorcontrib><title>TLR3 Can Directly Trigger Apoptosis in Human Cancer Cells</title><title>Journal of Immunology</title><addtitle>J Immunol</addtitle><description>TLRs function as molecular sensors to detect pathogen-derived products and trigger protective responses ranging from secretion of cytokines that increase the resistance of infected cells and chemokines that recruit immune cells to cell death that limits microbe spreading. Viral dsRNA participate in virus-infected cell apoptosis, but the signaling pathway involved remains unclear. In this study we show that synthetic dsRNA induces apoptosis of human breast cancer cells in a TLR3-dependent manner, which involves the molecular adaptor Toll/IL-1R domain-containing adapter inducing IFN-beta and type I IFN autocrine signaling, but occurs independently of the dsRNA-activated kinase. Moreover, detailed molecular analysis of dsRNA-induced cell death established the proapoptotic role of IL-1R-associated kinase-4 and NF-kappaB downstream of TLR3 as well as the activation of the extrinsic caspases. The direct proapoptotic activity of endogenous human TLR3 expressed by cancerous cells reveals a novel aspect of the multiple-faced TLR biology, which may open new clinical prospects for using TLR3 agonists as cytotoxic agents in selected cancers.</description><subject>Apoptosis - immunology</subject><subject>Base Sequence</subject><subject>Breast Neoplasms - genetics</subject><subject>Breast Neoplasms - immunology</subject><subject>Breast Neoplasms - pathology</subject><subject>Caspases - metabolism</subject><subject>Cell Line, Tumor</subject><subject>DNA, Neoplasm - genetics</subject><subject>eIF-2 Kinase - metabolism</subject><subject>Female</subject><subject>Humans</subject><subject>Interferon Type I - metabolism</subject><subject>Interleukin-1 Receptor-Associated Kinases</subject><subject>Intracellular Signaling Peptides and Proteins - metabolism</subject><subject>NF-kappa B - metabolism</subject><subject>Protein-Serine-Threonine Kinases - metabolism</subject><subject>RNA, Small Interfering - genetics</subject><subject>Signal Transduction</subject><subject>TNF Receptor-Associated Factor 6 - metabolism</subject><subject>Toll-Like Receptor 3 - agonists</subject><subject>Toll-Like Receptor 3 - genetics</subject><subject>Toll-Like Receptor 3 - metabolism</subject><issn>0022-1767</issn><issn>1550-6606</issn><issn>1365-2567</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtKw0AUhgdRbK0-gSBZ6SpxJnNflnipUBCkrodJOtNOyc1MQujbO6UV3QkHzuJ8_8_hA-AWwYRAIh93rqqGuikTxFkiEiIkOQNTRCmMGYPsHEwhTNM4XPkEXHm_gxAymJJLMEGMChpmCuRq-YGjTNfRk-tM0Zf7aNW5zcZ00bxt2r7xzkeujhZDFZjAFeGSmbL01-DC6tKbm9Oegc-X51W2iJfvr2_ZfBkXhPM-toVFuaQ2Fzhdm5TLnDCqMeWEmdxIIlPBmNb5GkojqOWUQSkN5GkKrSyoxTNwf-xtu-ZrML5XlfNF-EDXphm8YlxgDBH5F0RSYI4kCiA-gkXXeN8Zq9rOVbrbKwTVQa36UauCPCXUQW1I3Z3qh7wy69_MyWUAHo7A1m22Y7CpfKXLMuBIjeP4p-ob_j6Cyw</recordid><startdate>20060415</startdate><enddate>20060415</enddate><creator>Salaun, Bruno</creator><creator>Coste, Isabelle</creator><creator>Rissoan, Marie-Clotilde</creator><creator>Lebecque, Serge J</creator><creator>Renno, Toufic</creator><general>Am Assoc Immnol</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20060415</creationdate><title>TLR3 Can Directly Trigger Apoptosis in Human Cancer Cells</title><author>Salaun, Bruno ; Coste, Isabelle ; Rissoan, Marie-Clotilde ; Lebecque, Serge J ; Renno, Toufic</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c477t-fcf1b95fb832de279b465a35746ebe9492866aabd09e85f756099e07220f9c5f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Apoptosis - immunology</topic><topic>Base Sequence</topic><topic>Breast Neoplasms - genetics</topic><topic>Breast Neoplasms - immunology</topic><topic>Breast Neoplasms - pathology</topic><topic>Caspases - metabolism</topic><topic>Cell Line, Tumor</topic><topic>DNA, Neoplasm - genetics</topic><topic>eIF-2 Kinase - metabolism</topic><topic>Female</topic><topic>Humans</topic><topic>Interferon Type I - metabolism</topic><topic>Interleukin-1 Receptor-Associated Kinases</topic><topic>Intracellular Signaling Peptides and Proteins - metabolism</topic><topic>NF-kappa B - metabolism</topic><topic>Protein-Serine-Threonine Kinases - metabolism</topic><topic>RNA, Small Interfering - genetics</topic><topic>Signal Transduction</topic><topic>TNF Receptor-Associated Factor 6 - metabolism</topic><topic>Toll-Like Receptor 3 - agonists</topic><topic>Toll-Like Receptor 3 - genetics</topic><topic>Toll-Like Receptor 3 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Salaun, Bruno</creatorcontrib><creatorcontrib>Coste, Isabelle</creatorcontrib><creatorcontrib>Rissoan, Marie-Clotilde</creatorcontrib><creatorcontrib>Lebecque, Serge J</creatorcontrib><creatorcontrib>Renno, Toufic</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of Immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Salaun, Bruno</au><au>Coste, Isabelle</au><au>Rissoan, Marie-Clotilde</au><au>Lebecque, Serge J</au><au>Renno, Toufic</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TLR3 Can Directly Trigger Apoptosis in Human Cancer Cells</atitle><jtitle>Journal of Immunology</jtitle><addtitle>J Immunol</addtitle><date>2006-04-15</date><risdate>2006</risdate><volume>176</volume><issue>8</issue><spage>4894</spage><epage>4901</epage><pages>4894-4901</pages><issn>0022-1767</issn><eissn>1550-6606</eissn><eissn>1365-2567</eissn><abstract>TLRs function as molecular sensors to detect pathogen-derived products and trigger protective responses ranging from secretion of cytokines that increase the resistance of infected cells and chemokines that recruit immune cells to cell death that limits microbe spreading. Viral dsRNA participate in virus-infected cell apoptosis, but the signaling pathway involved remains unclear. In this study we show that synthetic dsRNA induces apoptosis of human breast cancer cells in a TLR3-dependent manner, which involves the molecular adaptor Toll/IL-1R domain-containing adapter inducing IFN-beta and type I IFN autocrine signaling, but occurs independently of the dsRNA-activated kinase. Moreover, detailed molecular analysis of dsRNA-induced cell death established the proapoptotic role of IL-1R-associated kinase-4 and NF-kappaB downstream of TLR3 as well as the activation of the extrinsic caspases. The direct proapoptotic activity of endogenous human TLR3 expressed by cancerous cells reveals a novel aspect of the multiple-faced TLR biology, which may open new clinical prospects for using TLR3 agonists as cytotoxic agents in selected cancers.</abstract><cop>United States</cop><pub>Am Assoc Immnol</pub><pmid>16585585</pmid><doi>10.4049/jimmunol.176.8.4894</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1767
ispartof Journal of Immunology, 2006-04, Vol.176 (8), p.4894-4901
issn 0022-1767
1550-6606
1365-2567
language eng
recordid cdi_proquest_miscellaneous_67833014
source MEDLINE; Access via Wiley Online Library; IngentaConnect Free/Open Access Journals; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection); PubMed Central; Alma/SFX Local Collection
subjects Apoptosis - immunology
Base Sequence
Breast Neoplasms - genetics
Breast Neoplasms - immunology
Breast Neoplasms - pathology
Caspases - metabolism
Cell Line, Tumor
DNA, Neoplasm - genetics
eIF-2 Kinase - metabolism
Female
Humans
Interferon Type I - metabolism
Interleukin-1 Receptor-Associated Kinases
Intracellular Signaling Peptides and Proteins - metabolism
NF-kappa B - metabolism
Protein-Serine-Threonine Kinases - metabolism
RNA, Small Interfering - genetics
Signal Transduction
TNF Receptor-Associated Factor 6 - metabolism
Toll-Like Receptor 3 - agonists
Toll-Like Receptor 3 - genetics
Toll-Like Receptor 3 - metabolism
title TLR3 Can Directly Trigger Apoptosis in Human Cancer Cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T20%3A49%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TLR3%20Can%20Directly%20Trigger%20Apoptosis%20in%20Human%20Cancer%20Cells&rft.jtitle=Journal%20of%20Immunology&rft.au=Salaun,%20Bruno&rft.date=2006-04-15&rft.volume=176&rft.issue=8&rft.spage=4894&rft.epage=4901&rft.pages=4894-4901&rft.issn=0022-1767&rft.eissn=1550-6606&rft_id=info:doi/10.4049/jimmunol.176.8.4894&rft_dat=%3Cproquest_cross%3E19837191%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19837191&rft_id=info:pmid/16585585&rfr_iscdi=true